All In Biotech

Drug Trial Radar · NCT05383742

Trial of a Six-Month Regimen of High-Dose Rifampicin, High-Dose Isoniazid, Linezolid, and Pyrazinamide Versus a Standard Nine-Month Regimen for the Treatment of Adults and Adolescents With Tuberculous Meningitis

A Phase II, Randomized, Open-Label Trial of a Six-Month Regimen of High-Dose Rifampicin, High-Dose Isoniazid, Linezolid, and Pyrazinamide Versus a Standard Nine-Month Regimen for the Treatment of Adults and Adolescents With Tuberculous Meningitis: Improved Management With Antimicrobial AGents Isoniazid rifampiciN LinEzolid for TBM (IMAGINE-TBM)

Last checked: Nov 20, 2026Latest source record: Nov 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 330 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

330

Planned (sponsor's estimate)

Start

Dec 7, 2023

Primary completion

Oct 1, 2029

Study completion Mar 5, 2030

Sponsor

Sponsor type
NIH
First posted
May 20, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 15 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to compare a 6-month regimen of high-dose rifampicin (RIF), high-dose isoniazid (INH), linezolid (LZD), and pyrazinamide (PZA) versus the World Health Organization (WHO) standard of care (SOC) treatment for tuberculosis meningitis (TBM).

Conditions

  • Tuberculous Meningitis

Interventions

  • Rifampicin (RIF)Drug

    Rifampicin 35 mg/kg

  • Isoniazid (INH)Drug

    Isoniazid 10 or15 mg/kg

  • Linezolid (LZD)Drug

    1200 mg

  • Pyrazinamide (PZA)Drug

    25 mg/kg

  • ethambutol (EMB)Drug

    20 mg/kg

  • RifampicinDrug

    10 mg/kg

  • IsoniazidDrug

    5 mg/kg

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Modified Rankin Scale (6-death, 5-severe disability, 4-moderately severe disability, 3-moderate disability, 2-slight disability, 1-no significant disability, 0-no symptoms)Time frame: At 48 weeks

Locations

18 sites in 12 countries. Site status is shown where the registry gives one.

  • Instituto de Pesquisas em AIDS do Rio Grande do Sul - IPARGS CRS (Site ID: 12201)

    Porto Alegre, Brazil · Recruiting

  • Instituto de Pesquisa Clinica Evandro Chagas (IPEC) CRS (Site ID: 12101)

    Rio de Janeiro, Brazil · Recruiting

  • Byramjee Jeejeebhoy Government Medical College (BJMC) CRS (Site ID: 31441)

    Pune, India · Recruiting

  • Moi University Clinical Research Center (MUCRC) CRS (Site ID: 12601)

    Eldoret, Kenya · Recruiting

  • Kenya Medical Research Institute/Walter Reed Project Clinical Research Center (KEMRI/WRP) CRS (Site ID: 12501)

    Kericho, Kenya · Recruiting

  • Malawi CRS (Site ID: 12001)

    Lilongwe, Malawi · Recruiting

  • Nutrición-Mexico CRS (Site ID: 32078)

    Mexico City, Mexico · Not yet recruiting

  • Barranco CRS (Site ID:11301)

    Lima, Peru · Not yet recruiting

  • Socios En Salud Sucursal Peru CRS (Site ID: 31985)

    Lima, Peru · Not yet recruiting

  • TB HIV Innovations and Clinical Research Foundation Corp (Site ID: 31981)

    Cavite, Philippines, Philippines · Not yet recruiting

  • Durban International Clinical Research Site CRS (Site ID:11201)

    Durban, South Africa · Not yet recruiting

  • Wits Helen Joseph Hospital CRS (Wits HJH CRS) (Site ID: 11101)

    Johannesburg, South Africa · Recruiting

  • Kilimanjaro Christian Medical Centre (KCMC) (Site ID: 5118)

    Moshi, Tanzania · Not yet recruiting

  • Chiangrai Prachanukroh Hospital NICHD CRS (Site ID: 5116)

    Chiang Mai, Thailand · Recruiting

  • Siriraj Hospital, Mahidol University NICHD CRS (Site ID: 5115)

    Bangkok, Bangkoknoi, Thailand · Not yet recruiting

  • Thai Red Cross AIDS Research Centre (TRC-ARC) CRS (Site ID: 31802)

    Bangkok, Pathumwan, Thailand · Not yet recruiting

  • National Lung Hospital CRS (Site ID: 32483)

    Vĩnh Phúc, Hanoi, Vietnam · Recruiting

  • Milton Park CRS (Site ID: 30313)

    Harare, Zimbabwe · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.